JEFFREY TILKIN: Open Payments
NPI 1578534483 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 30 payments from 6 companies in 2025. Trend: 2023 $76 · 2024 $231 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 16 | $294 |
| Neurocrine BioSciences, Inc. | 4 | $121 |
| Teva Pharmaceuticals USA, Inc. | 4 | $112 |
| Janssen Pharmaceuticals, Inc | 2 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Alkermes, Inc. | 1 | $29 |
Products named: COBENFY, INGREZZA, SPRAVATO, CAPLYTA, UZEDY, AUSTEDO XR, ARISTADA.
Industry payments across IL — which companies pay providers there.
